(NYSE: SNN) Smith & Nephew's forecast annual revenue growth rate of 6.09% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.15%.
Smith & Nephew's revenue in 2025 is $5,810,000,134.On average, 21 Wall Street analysts forecast SNN's revenue for 2025 to be $5,494,428,204,360, with the lowest SNN revenue forecast at $5,243,404,807,164, and the highest SNN revenue forecast at $5,698,055,575,512. On average, 21 Wall Street analysts forecast SNN's revenue for 2026 to be $5,791,092,219,228, with the lowest SNN revenue forecast at $5,511,982,288,080, and the highest SNN revenue forecast at $6,083,367,713,166.
In 2027, SNN is forecast to generate $6,089,511,642,468 in revenue, with the lowest revenue forecast at $5,731,408,334,580 and the highest revenue forecast at $6,443,226,429,426.